• Users Online: 135
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
LETTER TO THE EDITOR
Year : 2019  |  Volume : 46  |  Issue : 3  |  Page : 210

Association between microalbuminuria and metabolic syndrome in patients with rheumatoid arthritis


Department of Paediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq

Date of Submission18-Aug-2018
Date of Acceptance15-Sep-2018
Date of Web Publication15-Jul-2019

Correspondence Address:
Mahmood D Al-Mendalawi
PO Box 55302, Baghdad Post Office, Baghdad, 1111
Iraq
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/err.err_42_18

Rights and Permissions

How to cite this article:
Al-Mendalawi MD. Association between microalbuminuria and metabolic syndrome in patients with rheumatoid arthritis. Egypt Rheumatol Rehabil 2019;46:210

How to cite this URL:
Al-Mendalawi MD. Association between microalbuminuria and metabolic syndrome in patients with rheumatoid arthritis. Egypt Rheumatol Rehabil [serial online] 2019 [cited 2019 Oct 21];46:210. Available from: http://www.err.eg.net/text.asp?2019/46/3/210/262701





Sir, I read the interesting study by Abdelmonem et al. [1] on the association between microalbuminuria and metabolic syndrome (MetS) in Egyptian patients with rheumatoid arthritis (RA) published in the latest issue of Egypt Rheumatol Rehabil. On the basis of the Grundy criteria [2], the authors found that the prevalence of MetS was highly statistically significant in patients with RA (60%) compared with the control group (10%). The RA patients’ group had highly significantly elevated mean values of urinary microalbumin and urinary albumin to creatinine ratio compared with the control group [1]. I presume that these results ought to be interpreted with caution. This is based on the following methodological limitation related to the MetS definition criteria used in the study. It is obvious that in the clinical setting and researches, there are many criteria for MetS. These include the following: National Cholesterol Education Program Adult Treatment Panel III; International Diabetes Federation (IDF); American Heart Association; Joint Interim Statement; and WHO. There is inconsistent consensus on the precision of these criteria in diagnosing MS [3]. In Egypt, estimations of the prevalence of MetS using different criteria have yielded variable results, namely, 42.5% (National Cholesterol Education Program Adult Treatment Panel III definition), 43.8% (American Heart Association definition), 44.3% (IDF definition), 33.8% (IDF definition with Egyptian cut-offs), and 41.5% (Joint Interim Statement with Egyptian cut-offs) [4]. As many national associations have suggested their own diagnostic MetS criteria [5], I presume that the establishment of national Egyptian MetS definition criteria could better estimate the prevalence of MetS in patients with various health disorders. Despite the above-mentioned limitation, the high prevalence of MetS reported in patients with RA (60%) [1] should trigger the need for strict interventions to preserve renal functions and decrease future adverse cardiovascular outcomes.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Abdelmonem S, Eltanawy R, Ismail Y, Baraka E, Shoshan A. Association between microalbuminuria and metabolic syndrome in patients with rheumatoid arthritis. Egypt Rheumatol Rehabil 2018; 45:87–93.  Back to cited text no. 1
  [Full text]  
2.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:e285–e290.  Back to cited text no. 2
    
3.
Katsiki N, Athyros VG, Karagiannis A, Mikhailidis D. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. Curr Vasc Pharmacol 2014; 12:627–641.  Back to cited text no. 3
    
4.
Assaad-Khalil SH, Mikhail MM, Aati TA, Zaki A, Helmy MA, Megallaa MH et al. Optimal waist circumference cutoff points for the determination of abdominal obesity and detection of cardiovascular risk factors among adult Egyptian population. Indian J Endocrinol Metab 2015; 19:804–810.  Back to cited text no. 4
    
5.
Xing Y, Xu S, Jia A, Cai J, Zhao M, Guo J et al. Recommendations for revision of Chinese diagnostic criteria for metabolic syndrome: a nationwide study. J Diabetes 2018; 10:232–239.  Back to cited text no. 5
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References

 Article Access Statistics
    Viewed63    
    Printed7    
    Emailed0    
    PDF Downloaded26    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]